redequities

377 results found.

Top Stocks matching your search for "red equities"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
ARE

Alexandria Real Estate Equities Inc.

-26.29%

$166.83 - $122.97

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 1, 2023

Alexandria Real Estate Equities upgraded by StockNews.com to hold.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SRTS

Sensus Healthcare Inc

-41.61%

$9.06 - $5.29

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 21, 2023

$SRTS has a Return On Equity of 56.73%.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
META

Meta Platforms Inc

5.50%

$191.62 - $202.16

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 30, 2023

$META has a Return On Equity of 23.23%.

Jan, 17, 2023

$META has a Return On Equity of 23.23%.

ARE

Alexandria Real Estate Equities Inc.

-26.29%

$166.83 - $122.97

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 1, 2023

Alexandria Real Estate Equities upgraded by StockNews.com to hold.

SRTS

Sensus Healthcare Inc

-41.61%

$9.06 - $5.29

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

META

Meta Platforms Inc

5.50%

$191.62 - $202.16

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 30, 2023

$META has a Return On Equity of 23.23%.

Jan, 17, 2023

$META has a Return On Equity of 23.23%.

Jan, 16, 2023

$META has a Return On Equity of 23.23%.

Jan, 13, 2023

$META has a Return On Equity of 23.23%.

Jan, 11, 2023

$AMZN $TSLA $META $COIN with the imminent dollar crash, these undervalued equities are poised to explode A LOT HIGHER

Dec, 5, 2022

I am so proud to own this equity.

Nov, 11, 2022

One of my favorite value/growth/contrarian equities of this quarter.